搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ENDPOINTS NEWS
4 小时
Sanofi invests in new radioligand partner Orano Med, buying 16% stake for €300M
A month after making a foray into the bustling radioligand field, Sanofi is further allying itself with Orano Med, paying ...
ENDPOINTS NEWS
14 小时
Compounding association to ask for clarity around tirzepatide's shortage ...
The Alliance for Pharmacy Compounding (APC) wants clarity around the FDA’s decision to reconsider tirzepatide’s removal from ...
ENDPOINTS NEWS
14 小时
Bavarian Nordic's mpox vaccine was safe and spurred promising immune response ...
Bavarian Nordic’s mpox vaccine Jynneos generated a similar immune response in adolescents as it did in adults, offering ...
ENDPOINTS NEWS
15 小时
First clinical test of RNA editing restores missing protein in genetic dis ...
An experimental therapy designed to change a single letter of short-lived mRNA molecules has corrected a genetic mutation ...
ENDPOINTS NEWS
19 小时
FDA places hold on Novavax's Covid-flu and standalone influenza vaccines
Novavax’s post-Covid path ran into a speed bump Wednesday, as the company announced a clinical hold on its Covid-influenza ...
ENDPOINTS NEWS
19 小时
Medicaid startup Waymark publishes study proving its program slashes ER ...
Investors have been placing bets into startups that help members of low-income households on Medicaid insurance get care. A ...
ENDPOINTS NEWS
21 小时
Facing a critical week, Pfizer confronts an unsparing foe in Starboard
Starboard Value may have lost its first skirmish with Pfizer. But the activist investor has a track record of protracted, ...
ENDPOINTS NEWS
23 小时
Takeda parts ways with Wave Life Sciences even with Huntington’s trial win
Takeda will not move forward with Wave Life Sciences on a Huntington’s disease drug, ending their collaboration that first ...
ENDPOINTS NEWS
23 小时
Q&A: Sanofi’s R&D head reflects on his first year, a post-Dupixent future, and find ...
Almost a year ago, Sanofi made history for the wrong reasons. Last October, CEO Paul Hudson announced strategic changes ...
ENDPOINTS NEWS
19 小时
Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China
Plus, news about TenNor Therapeutics, Gan & Lee Pharmaceuticals, Orasis and Optus Pharmaceuticals: Exscientia receives $15M milestone from Sanofi: The companies are advancing two programs as ...
ENDPOINTS NEWS
1 天
Seeking to treat obesity drug side effect, Neurogastrx releases data on ...
Neurogastrx believes its drug could treat one of the most troublesome side effects of one of the industry's biggest ...
ENDPOINTS NEWS
1 天
Sacklers call opioid-related fraud claims 'utterly meritless'
Months after Purdue Pharma’s bankruptcy plan was foiled by the Supreme Court, its previous owners are bracing for a legal ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈